Peer Review reports
From: MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib
| Original Submission | ||
|---|---|---|
| 22 Jan 2016 | Submitted | Original manuscript |
| Author responded | Author comments | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Author responded | Author comments | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Author responded | Author comments | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 21 Jul 2016 | Editorially accepted | |
| 27 Jul 2016 | Article published | 10.1186/s12885-016-2598-1 |
You can find further information about peer review here.